Critically Ill: Clinical Trials

4 trials for Critically Ill, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 23Completed 3

Follow Critically Ill: new trials by email Literature Review of Critically Ill trials Research Report on Critically Ill

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Coated Devices to Decrease Infection in the Intensive Care Unit
Coated devices, Control - Critically Ill
Phase 1 / Phase 2CompletedHospital do Coracao1032019-04-062020-03-09
Plasma Pharmacokinetics (PK) & Lung Penetration of Ceftolozane/Tazobactam in Participants With Pneumonia (MK-7625A-007)
Ceftolozane/Tazobactam - Multiple Doses, Ceftolozane/Tazobactam - Single Dose - Critically Ill, Pneumonia
Phase 1CompletedCubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)372015-02-052019-08-28
TEAM: A Trial of Early Activity and Mobility in ICU
Early mobilisation - Critically Ill
Phase 1 / Phase 2CompletedAustralian and New Zealand Intensive Care Research Centre502013-08-012018-08-22
The Use of Methadone in Newborn Infants
Methadone - Premature Birth of Newborn, Critically Ill
Phase 1 / Phase 2CompletedJohn van den Anker602010-12-012018-07-26

Narrower conditions

Critical Illness (4)  ·  Pneumonia (1)  ·  Pneumonia, Ventilator-Associated (1)  ·  Premature Birth (1)  ·  Sepsis (1)

Broader conditions

Disease Attributes (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Cross Infection (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Healthcare-Associated Pneumonia (1)  ·  Iatrogenic Disease (1)  ·  Inflammation (1)  ·  Obstetric Labor Complications (1)  ·  Obstetric Labor, Premature (1)  ·  Pneumonia (1)

Interventions

Inulin (1)  ·  Methadone (1)  ·  Rehabilitation (1)  ·  Tazobactam (1)  ·  ceftolozane (1)  ·  sinistrin (1)

Sponsors

Australian and New Zealand Intensive Care Research Centre (1)  ·  Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1)  ·  Hospital do Coracao (1)  ·  John van den Anker (1)

Countries

Australia (1)  ·  Brazil (1)  ·  New Zealand (1)  ·  United States (1)

Top investigators

Alexandre Biasi, MD/PhD (1)  ·  Carol L Hodgson, PhD (1)

Results publications

PMID 30805946, PMID 32211756, PMID 32526149, PMID 33567333